Skip to main content
logo
Valion Bio, Inc. (VBIO)
NASDAQ: VBIO · Real-Time Price · USD
2.200
+0.090 (4.27%)
Sep 16, 2026, 2:22 PM EDT - Market open

Valion Bio Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
---1.181.841.26
Revenue Growth
----36.09%46.38%46.16%
Gross Profit
---0.290.3-0.04
Operating Income
-16.9-7.9-4.48-8.25-10.1-5.63
Net Income
-19.23-8.88-5.66-8.24-10.1-8.49
Earnings Per Share
-210.20-192.08-491.95---
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
2.1112.6523.43.5212.98
Total Debt
17.416.45-0.370.530.71
Net Cash (Debt)
-15.36.1923.032.9912.27
Net Cash Growth
-209.24%-33.84%1.31%-75.65%1311.62%
Net Cash Per Share
-167.25133.94174.16---

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-14.58-7-5.73-8.51-8.92-5.61
Capital Expenditures
-0.1-0.04--0.12-0.01-
Free Cash Flow
-14.67-7.04-5.73-8.63-8.93-5.61
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
---24.40%16.25%-3.02%
Operating Margin
----701.11%-548.80%-448.13%
Pretax Margin
----701.02%-548.70%-675.74%
Profit Margin
----701.02%-548.70%-675.74%
FCF Margin
----733.76%-485.33%-446.46%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
---2.243.3629.91